As filed with the Securities and Exchange Commission on October 13, 2020

Registration No. 333-                

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

ObsEva SA

(Exact name of Registrant as specified in its charter)

 

 

 

Switzerland   Not applicable
(State or other jurisdiction of
Incorporation or organization)
  (I.R.S. Employer
Identification No.)

Chemin des Aulx, 12

1228 Plan-les-Ouates

Geneva, Switzerland

(Address of principal executive offices) (Zip code)

2017 Equity Incentive Plan

(Full title of the plan)

Cogency Global Inc.

122 East 42nd Street, 18th Floor

New York, New York 10168

(212) 947-7200

(Name and address of agent for service) (Telephone number, including area code, of agent for service)

 

 

Copies to:

Divakar Gupta

Ryan Sansom

Marianne Sarrazin

Cooley LLP

55 Hudson Yards

New York, NY 10001

(212) 479-6000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Securities
to be Registered
  Amount to be
Registered(1)
  Proposed
Maximum
Offering
Price Per
Share(2)
 

Proposed
Maximum
Aggregate

Offering Price(2)

 

Amount of

Registration
Fee

Common Shares, par value CHF 0.0769 per share

  3,204,124 shares(3)   $2.46   $7,882,145.04   $859.94

 

 

(1)

Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional common shares of CHF 0.0769 each par value (the “Common Shares”) of the Registrant that become issuable under the 2017 Equity Incentive Plan, as amended (the “2017 Plan”), by reason of any share dividend, share split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding Common Shares.

(2)

Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) promulgated under the Securities Act. The offering price per share and the aggregate offering price are based upon $2.46, which is the average of the high and low prices of the Registrant’s Common Shares as reported on the Nasdaq Global Select Market on October 12, 2020.

(3)

Represents 3,204,124 Common Shares added to the shares authorized for issuance under the 2017 Plan pursuant to an amendment to such plan approved by the Registrant’s stockholders on June 9, 2020.

 

 

 


INCORPORATION OF DOCUMENTS BY REFERENCE

This Registration Statement is being filed for the purpose of increasing the number of securities of the same class as other securities for which Registration Statements of the Registrant on Form S-8 relating to the same employee benefit plan are effective. The Registrant previously registered Common Shares for issuance under the 2017 Plan under Registration Statements on Form S-8  filed with the Securities and Exchange Commission (the “Commission”) on February 22, 2017 (File No. 333-216170) and on May 21, 2019 (File No. 333-231629). Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registration Statements referenced above.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

ITEM 8.

EXHIBITS

 

Exhibit
Number

  

Description

4.1    Articles of Association of the Registrant, as currently in effect (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form F-3 (File No. 333-233069), filed with the Securities and Exchange Commission on August 7, 2019).
5.1    Opinion of Lenz & Staehelin, Swiss counsel of the Registrant, as to the validity of the common shares (filed herewith).
23.1    Consent of PricewaterhouseCoopers SA, independent registered public accounting firm (filed herewith).
23.2    Consent of Lenz & Staehelin (included in Exhibit 5.1).
24.1    Power of Attorney (included on the signature page of this Form S-8).
99.1    2017 Equity Incentive Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form F-1/A (File No. 333- 215383), filed with the Securities and Exchange Commission on January 17, 2017).
99.2(3)    Form of Stock Option Grant Notice and Stock Option Agreement under 2017 Equity Incentive Plan (incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form F-1/A (File No. 333- 215383), filed with the Securities and Exchange Commission on January 17, 2017, and incorporated by reference herein).


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Geneva, Switzerland, on this 13th day of October, 2020.

 

OBSEVA SA
By:  

/s/ Ernest Loumaye

  Ernest Loumaye
  Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Ernest Loumaye and Fabien de Ladonchamps, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

  

Date

/s/    Ernest Loumaye        

Ernest Loumaye

   Chief Executive Officer and Director
(Principal Executive Officer)
   October 13, 2020

/s/    Fabien de Ladonchamps        

Fabien de Ladonchamps

  

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

   October 13, 2020

/s/    Frank Verwiel        

Frank Verwiel

   Chairperson of the Board of Directors    October 13, 2020

/s/    Annette Clancy        

Annette Clancy

   Director    October 13, 2020

/s/    Barbara Duncan        

Barbara Duncan

   Director    October 13, 2020


/s/    James I. Healy        

James I. Healy

   Director    October 13, 2020

/s/    Ed Mathers        

Ed Mathers

   Director    October 13, 2020

/s/    Rafaèle Tordjman        

Rafaèle Tordjman

   Director    October 13, 2020

/s/    Jacky Vonderscher        

Jacky Vonderscher

   Director    October 13, 2020

/s/    Colleen A. DeVries        

Colleen A. DeVries

Senior Vice-President on behalf of
Cogency Global Inc.

   Authorized Representative in the United States    October 13, 2020

Exhibit 5.1

 

ObsEva SA

Attn. Mr. Fabien de Ladonchamps

Chemin des Aulx 12

1228 Plan-les-Ouates

  

Lenz & Staehelin

Route de Chêne 30

CH-1211 Genève 6

Tél: +41 58 450 70 00

Fax: +41 58 450 70 01

 

Brandschenkestrasse 24

CH-8027 Zurich

Tél: +41 58 450 80 00

Fax: +41 58 450 80 01

 

Avenue de Rhodanie 58

CH-1007 Lausanne

Tél: +41 58 450 70 00

Fax: +41 58 450 70 01

 

www.lenzstaehelin.com

 

 

Geneva, October 13, 2020

Registration Statement on Form S-8

Ladies and Gentlemen,

We have examined the Registration Statement on Form S-8 to be filed by you with the Securities and Exchange Commission on or around October 13, 2020 (the “Registration Statement”), in connection with the registration under the Securities Act of 1933, as amended, of additional 3,204,124 common shares, par value of 1/13 of CHF 1 each, of ObsEva SA, a Swiss corporation (the “Shares”), subject to issuance by ObsEva SA (the “Company”) upon the exercise of stock options granted under the 2017 Equity Incentive Plan, as amended by the general meeting of shareholders of the Company on June 9, 2020 (the “Plan”). As your legal counsel, we have examined, strictly under Swiss law, the proceedings taken and proposed to be taken by you in connection with the issuance and sale of such Shares under the Plan.

Strictly limited to Swiss law and assuming (i) that all Shares are issued and sold in the manner referred to in the Plan and pursuant to the agreements which accompany the Plan, and (ii), as to any new Shares to be issued out of the conditional capital of the Company that may be used to satisfy any obligations of the Company under the Plan, the due execution and delivery of, and the taking of necessary actions under, an agreement between the Company and a Swiss bank for the issuing of Shares from the Company’s conditional capital, it is our opinion that any Shares to be issued will be validly issued, fully paid and non-assessable.

 

Associés Genève: Shelby R. du Pasquier • Guy Vermeil • Mark Barmes* • François Rayroux • Jean-Blaise Eckert • Daniel Tunik •

Olivier Stahler • Andreas Rötheli • Xavier Favre-Bulle • Benoît Merkt • David Ledermann • Jacques Iffland • Daniel Schafer • Miguel Oural • Fedor Poskriakov • Frédéric Neukomm • Cécile Berger Meyer • Rayan Houdrouge · Floran Ponce

Zurich: Patrick Hünerwadel • Stefan Breitenstein • Matthias Oertle • Martin Burkhardt • Heini Rüdisühli • Marcel Meinhardt •

Patrick Schleiffer • Thierry Calame • Beat Kühni • Lukas Morscher • Tanja Luginbühl • Prof. Jürg Simon • Matthias Wolf • Hans-Jakob Diem

Prof. Pascal Hinny • Harold Frey • Marcel Tranchet • Tino Gaberthüel • Astrid Waser • Stephan Erni • Roland Fischer  Dominique Müller

Lausanne: Lucien Masmejan

 

Admitted to the Bar    * Solicitor (England & Wales)


We hereby consent to the filing of this opinion as an exhibit to the Registration Statement filed on the date hereof. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.

This opinion shall be governed by and construed in accordance with the laws of Switzerland.

Very truly yours,

/s/ Lenz & Staehelin

Lenz & Staehelin

 

2

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of ObsEva SA of our report dated March 5, 2020 relating to the financial statements, which appears in ObsEva SA’s Annual Report on Form 20-F for the year ended December 31, 2019.

/s/ PricewaterhouseCoopers SA

Geneva, Switzerland

October 13, 2020